Combination Statin, Acetylsalicylic Acid and Dutasteride Use in Prostate Cancer

NCT01428869 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 8231

Last updated 2011-09-09

No results posted yet for this study

Summary

The purpose of this study is to assess whether there is any interaction between statins, acetylsalicylic acid (ASA) and dutasteride on protection from prostate cancer, the development of high grade prostate cancer, or lower urinary tract symptoms.

Conditions

Sponsors & Collaborators

  • University Health Network, Toronto

    lead OTHER

Principal Investigators

  • Neil E Fleshner, MD MPH FRCSC · University Health Network, Toronto

Eligibility

Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-08-31
Completion
2011-08-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01428869 on ClinicalTrials.gov